<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-121841</identifier>
<setSpec>0034-0618</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Biotechnological proposal for cervical cancer treatment using liposomes</dc:title>
<dc:description xml:lang="en">Drug nanosystems are an excellent option to form efficient and safe pharmaceutical systems. Our team has developed methodology based on the use of Interleukin 2 (IL-2) which has proven very effective in antitumor therapy, but systemic administration is limited by its high toxicity. The present work discusses in vivo evaluation of the tumor using IL-2 carried in liposomes against IL-2 free, and also addresses an important and necessary step for the future use of IL-2 liposomes in biotechnology therapy for patients with carcinoma of the cervix: the early pharmaceutical stability studies (AU)</dc:description>
<dc:creator>Gil-Alegre, María Esther</dc:creator>
<dc:creator>Weiss-Steider, Benito</dc:creator>
<dc:creator>Corona-Ortega, María Teresa</dc:creator>
<dc:creator>Rangel-Corona, Rosalva</dc:creator>
<dc:creator>Soto-Vázquez, Ramón</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Los nanotransportadores de fármacos son una excelente opción para formar sistemas farmacéuticos eficientes y seguros. Interleucina 2 (IL-2) es eficaz en la terapia antitumoral, sin embargo su administración sistémica se ha limitado por su alta toxicidad. En el presente trabajo se aborda la investigación en animales del tratamiento antitumoral con IL-2 transportada en liposomas frente a IL-2 libre, y se aborda un paso imprescindible para el futuro uso de los liposomas con IL-2 como terapia biotecnológica para pacientes con carcinoma de cérvix: los primeros estudios de estabilidad farmacéutica (AU)</dc:description>
<dc:source>An Real Acad Farm;80(1): 179-191, ene.-mar. 2014. ilus</dc:source>
<dc:identifier>ibc-121841</dc:identifier>
<dc:title xml:lang="es">Propuesta biotecnológica para el tratamiento del cáncer de cérvix uterino, empleando liposomas</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d2623^s22057</dc:subject>
<dc:subject>^d52497^s22074</dc:subject>
<dc:subject>^d8255^s22078</dc:subject>
<dc:subject>^d4255</dc:subject>
<dc:subject>^d29489^s22078</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d4415</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:type>article</dc:type>
<dc:date>201403</dc:date>
</metadata>
</record>
</ibecs-document>
